CG Oncology (CGON) Interest & Investment Income (2023 - 2026)
CG Oncology posted quarterly Interest & Investment Income of $6.3 million for Q1 2026, down 18.83% year-on-year from $7.7 million in Q1 2025, and down 15.53% on a QoQ basis from $7.4 million in Q4 2025.
CG Oncology (CGON) has 4 years of Interest & Investment Income data on file, last reported at $6.3 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 18.83% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $28.5 million (down 1.23% YoY), and the FY2025 full-year result was $29.9 million, up 12.42% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $6.3 million, down from $7.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7.9 million in Q3 2024 and bottomed at $771000.0 in Q2 2023.
- The 4-year median for Interest & Investment Income is $6.3 million (2026), against an average of $5.4 million.
- The widest annual swing landed in 2024, when Interest & Investment Income jumped 800.52%; it then decreased 18.83% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $2.8 million in 2023, then surged by 122.72% to $6.2 million in 2024, then grew by 19.2% to $7.4 million in 2025, then fell by 15.53% to $6.3 million in 2026.
- The last three Interest & Investment Income figures came in at $6.3 million (Q1 2026), $7.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | 6.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.29 Mn |
| Dec 31, 2025 | 7.44 Mn |
| Sep 30, 2025 | 7.42 Mn |
| Jun 30, 2025 | 7.32 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Dec 31, 2024 | 6.25 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 6.94 Mn |
| Mar 31, 2024 | 5.54 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 771,000.00 |
| Mar 31, 2023 | 1.05 Mn |